Gamma interferon, an immune lymphokine that protects mouse macrophages against infection by several parasites, was ineffective against Mycobacterium lepraemurium. On the contrary, it significantly stimulated multiplication of M. lepraemurium in the macrophages. Simultaneous treatment of macrophages with gamma interferon and interleukin-4 or interleukin-2 or a combination of all three did not enhance the macrophage resistance to infection with M. lepraemurium, but instead stimulated growth of M. lepraemurium.
Gamma interferon, an immune lymphokine that protects mouse macrophages against infection by several parasites, was ineffective against Mycobacterium lepraemurium. On the contrary, it significantly stimulated multiplication of M. lepraemurium in the macrophages. Simultaneous treatment of macrophages with gamma interferon and interleukin-4 or interleukin-2 or a combination of all three did not enhance the macrophage resistance to infection with M. lepraemurium, but instead stimulated growth of M. lepraemurium.
Mvcobac'teriiun lepraerniiriiiin is an intracellular rodent pathogen which multiplies in macrophages. Injected intravenously in mice, it causes a slowly progressive, ultimately fatal systemic infection. It multiplies copiously in the mouse, which in late stages of the disease harbors enormous bacterial populations. The reason for this profuse multiplication is unknown; however, it does seem to be associated with profound suppression of cellular immunity (8) .
Lymphokines and especially gamma interferon (IFN-y) are instruments of cell-mediated immunity, generally activating macrophages to resist or kill various intracellular pathogens (7) . Their roles in antimycobacterial immunity are somewhat confusing. Crude lymphokine-activated mouse macrophages have been reported to kill M)ycobateri-hin microti (10) . Recombinant IFN-y (rIFN-y) appears to protect mouse macrophages against M. tuberciulosis (5, 9) but does not protect human macrophages, in which it may actually have an anti-immune effect and enhance bacterial growth (3, 4, 9) . Bovine alpha IFN has been reported to protect bovine monocytes but not monocyte-derived macrophages against Mycobacteriiln paratuberculosis, a close relative of M. lepraemurium (12) . Crude lymphokines were found to activate peritoneal mouse macrophages to stop M. lepraernuriuin replication and to activate bone marrow macrophages to kill M. leprcaemniiiiriin (1) . Here we report evidence that mouse rIFN--y can significantly enhance M. lepraemuriiim multiplication in cultured mouse peritoneal macrophages. The combination of IFN with either recombinant interleukin 2 (IL-2) or recombinant interleukin-4 (IL-4) or both had no effect on macrophage resistance to M. lepr(aenllriiln infection.
Resident peritoneal macrophages obtained from murine pathogen-free Swiss Webster mice (Taconic) by saline lavage were cultured on glass cover slips in glass Leighton tubes in Dulbecco modified Eagle medium (6) supplemented with 10% heat-inactivated fetal calf serum and lymphokines (rIFN-y, obtained from Genentech, was provided by P. A. Campbell, National Jewish Center for Immunology and Respiratory Medicine in the framework of our ongoing collaborative studies; recombinant IL-2 and recombinant IL-4 were purchased from the Genzyme Corporation, Boston, Mass.). The medium was replaced every 3 to 4 days, and the lymphokines were continuously present during the Corresponding author.
infection. The macrophages were infected with M. lepraerniriuin harvested from the livers of M. lepraerniiriirninfected BALB/c mice and purified by centrifugation on Percoll gradients (11) . A one-use portion from a standard suspension of M. lepraemiiriini stored at -80°C was used at 2 x 107 acid-fast bacilli per ml in Hanks balanced salt solution without opsonization, for a proportion of bacteria to cultured macrophages of approximately 20:1. The infection was for 50 min at 37°C in 5% CO2 and 95% air. Unphagocytized bacteria were washed off with saline. The infected macrophages were incubated for the periods indicated. Representative cultures were fixed in methanol and stained with carbol fuchsin, and the number of acid-fast bacilli per macrophage was determined from counting at least 200 macrophages on each cover slip. The results were expressed as mean acid-fast bacilli per macrophage ± standard deviation for three observations.
Macrophages incubated with IFN-y or IL-4 or both exhibited an increase in size and spreading on surfaces compared with control or IL-2-incubated macrophages. IFN-y-treated macrophages showed a slightly lower rate of phagocytosis than did the control macrophages, but in general, addition of the lymphokines did not have a significant effect on the percentage of macrophages infected with M. lepraeinuriim. The numbers of M. lepraemnurium in control macrophages increased approximately six times in the first 12 days of culture but did not change much in an additional 2 weeks of incubation (see medium control group, Fig. 1 ). This shows that rIFN-y in the medium markedly stimulated M. lepraeiniriiin replication in the macrophages. They increased approximately 18-, 24-, and 26-fold, depending on the dose of interferon. Higher concentrations (5,000 and 10,000 U/ml) were used in additional experiments. While these also tended to stimulate intracellular M. lepraemnriumn multiplication, they were not well tolerated by the macrophages; a concentration of 10,000 U/ml exerted a toxic effect on macrophages.
Recent studies have shown that some macrophage antimicrobial activities can be induced by two or three lymphokines (2) . To test this possibility in our system, macrophage monolayers were incubated with IL-4 alone or simultaneously with IFN and IL-4 for 24 h and then infected with M. lepr-aenuril^ii. Under neither circumstance were macrophages stimulated to resist M. lepraetnurium multiplication. Still, when lFN and IL-4 were used in combination, a slight antagonism of the IFN effect was suggested (Fig. 2) . Subse- 
